AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.75+0.28 (+4.33%)
At close: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 6.62 |
| Open | 6.58 |
| Bid | 6.69 x 1100 |
| Ask | 6.70 x 800 |
| Day's Range | 6.58 - 7.03 |
| 52 Week Range | 3.50 - 18.24 |
| Volume | 848,222 |
| Avg. Volume | 2,533,003 |
| Market Cap | 231.935M |
| Beta (5Y Monthly) | 1.26 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.66 |
| Earnings Date | May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 22.75 |
- Zacks
AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Tops Revenue Estimates
AVEO (AVEO) delivered earnings and revenue surprises of -30.91% and 42.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
AVEO Oncology Reports First Quarter 2021 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO), a commercial and clinical development stage biopharmaceutical company, today reported financial results for the first quarter ended March 31, 2021 and provided a business update.
- ACCESSWIRE
AVEO Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 10, 2021 / AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 10, 2021 at 4:30 PM Eastern Time.
© 2021 Verizon Media. All rights reserved.
